AzTrials
AzTrials

Patellar TendinopathyNCT04550013

Blood Flow Restriction Training for Treatment of Chronic Patellar Tendinopathy

A study testing Heavy-Slow Resistance training and Low-Load Blood Flow Restriction training in people with Patellar Tendinopathy and Jumper's Knee, run by Bispebjerg Hospital at 1 site in Denmark.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate the clinical and functional outcome of a 12-week rehabilitation regime consisting of Low-Load Blood Flow Restriction compared to Heavy-Slow Resistance training in male patients with chronic unilateral patellar tendinopathy. Read more about this study

Who is it for?
Ages 18 to 70 years, men only
Conditions the study is for
Patellar Tendinopathy, Jumper's Knee
What is being tested?
Heavy-Slow Resistance training and Low-Load Blood Flow Restriction training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteDenmark
Study dates
1 Aug 2020to 23 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Unilateral patellar tendinopathy
  • Chronic (symptoms >3 months)
  • Pain of ≥ 4 during preferred sporting activity on the numerical pain rating scale (NRS; with 0 being no pain and 10 being the worst imaginable pain)
  • Ultrasonographical tendon swelling
  • Ultrasonographical hypo-echoic area with doppler

Who cannot join

  • Bilateral tendinopathy
  • Cardiovascular diseases
  • Diabetes
  • Smoking
  • Previous surgery or trauma to the knee joint with an effect on the presenting clinical condition
  • Participants must not have been enrolled in a resistance based-rehabilitation program for the affected patellar tendon within the previous three months
  • Previous corticosteroid injection for patellar tendinopathy

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Department of Physical and Occupational Therapy / Institute of Sports Medicine Copenhagen, Bispebjerg Hospital

    Copenhagen, 2400

Other trials in Denmark

About this study

Official title: The Effect of Low-Load Resistance Training With Blood Flow Restriction for Treatment of Chronic Patellar Tendinopathy - A Randomized Clinical Trial

The purpose of this study is to investigate the clinical and functional outcome of a 12-week rehabilitation regime consisting of Low-Load Blood Flow Restriction compared to Heavy-Slow Resistance training in male patients with chronic unilateral patellar tendinopathy.

Read the detailed description

Chronic tendinopathy represents a considerable problem in both elite and recreational athletes, and symptoms may affect athletic performance and reduce or even result in retirement from sports participation. The current best treatment is considered to be heavy-slow resistance training (HSRT); however, not all patients are able to cope with heavy exercise loads. Therefore, low-load strength training performed under partial blood flow restriction may be a clinically relevant rehabilitation tool.

This project aims to investigate a new innovative intervention to treat chronic unilateral patellar tendinopathy in male individuals using strength training with low-load muscle contractions performed under partial blood flow restriction (LL-BFR), and to compare the resulting treatment outcome to that of the current best practice (HSRT). Specifically, the effect of LL-BFR will be investigated using a randomized controlled trial design with two groups; 1) a low-load blood flow restriction training program, and 2) a heavy-load slow strength training program. A total sample size of 36 participants are needed when assuming a 10 % dropout.

The training protocol consist of three weekly training sessions during a 12-week rehabilitation period. The primary outcome is measured using the Single-Leg Decline Squat at 12-week.

If LL-BFR proves to be an effective treatment strategy for tendinopathy, it can easily be implemented in daily clinical practice.

Being tested
Heavy-Slow Resistance training, Low-Load Blood Flow Restriction training
Keywords
Patellar tendinopathy, Overuse Injury, Rehabilitation
Medical subject headings
Cumulative Trauma Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Heavy-Slow Resistance trainingOther

    Resistance training for knee extensors. The exercise will be performed at 80% of 1 RM and slowly (6 s/repetition).

  • Low-Load Blood Flow Restriction trainingOther

    Resistance training for knee extensors. The exercise will be performed at 30% of 1 RM and with a relative Artery Occlusion Pressure of 80%

Study groups in NCT04550013
Study groupRoleWhat they receive
Heavy-Slow Resistance trainingActive comparatorHeavy-Slow Resistance training. Three times weekly for 12 weeks.
Receives: Other: Heavy-Slow Resistance training
Low-Load Blood Flow Restriction trainingExperimentalLow-Load Blood Flow Restriction training. Three times weekly for 12 weeks
Receives: Other: Low-Load Blood Flow Restriction training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline - 12 weeks using the clinical functional test Single-Leg Decline Squat measured on the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)

    Single-Leg Decline Squat is a reliable patellar tendon pain provocation test used to assess pain during function.

    Measured: Baseline-12 weeks.

Secondary outcomes (12)
  1. Single-Leg Decline Squat test

    A reliable patellar tendon pain provocation test, will be used to assess pain during function using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)

    Measured: Baseline, 3, 6 weeks + 1 year follow-up

  2. Pain rating on Numeric Rating Scale (NRS; 0 = no pain; 10 = worst imaginable pain) during training.

    Measured: Baseline, 3, 6 and 12 weeks + 1 year follow-up

  3. Self-reported activity level of sporting activities (hours/week)

    Participants will self-report how many hours a week they are performing sporting activities: We will monitor to see if they decrease, maintain or increase hours per week of sporting activity

    Measured: Baseline, 3, 6 and 12 weeks + 1 year follow-up

  4. Doppler activity using Ultrasonography power Doppler

    Using Ultrasonography, we will measure Doppler activity within the affected tendon and use ImageJ for the analysis

    Measured: Baseline, 3, 6 and 12 weeks + 1 year follow-up

  5. Tendon thickness measured using Ultrasonography

    Measured: Baseline, 3, 6 and 12 weeks + 1 year follow-up

  6. Muscle cross-sectional area measured using Ultrasonography

    We will measure the muscle thickness of vastus lateralis using ultrasonography

    Measured: Baseline, 3, 6 and 12 weeks + 1 year follow-up

  7. Muscle structure measured by MRI

    Measured: Baseline and 12 weeks

  8. Tendon dimensions measured by MRI

    Measured: Baseline and 12 weeks

  9. Isometric Muscle Strength

    Maximal muscle strength of the knee extensors is obtained during a maximal isometric voluntary contractions

    Measured: Baseline, 3, 6 and 12 weeks + 1 year follow-up

  10. Pain Pressure Threshold

    Measured by a handheld pressure algometry at most painful site, Apex Patellar, Tibialis Anterior and Extensor Carpi Radialis.

    Measured: Baseline, 3, 6 and 12 weeks + 1 year follow-up

  11. Adverse events

    Participants will self-report adverse events during intervention period and at 1 year follow-up

    Measured: Baseline-12 weeks + 1 year follow-up

  12. Victorian Institute of Sports Assessment - Patellar Tendinopathy

    The VISA-P is a questionnaire that assesses symptoms, simple test of function, and the ability to play sports. Max score for asymptomatic is 100 and worst score is 0

    Measured: Baseline, 3, 6 and 12 weeks + 1 year follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Sep 2020
  2. Study start1 Aug 2020
  3. Primary completion30 Dec 2022
  4. Study completion23 Sep 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04550013
Sponsor's protocol ID
A2359
Status last verified
Jan 2023
First submitted
20 Aug 2020
Last updated
18 Jan 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Hjortshoej MH, Juneja H, Svensson RB, Herzog RB, Lundgaard-Nielsen M, Nielsen FK, Wulff MW, Olsen AE, Nybing JD, Hansen P, Petersen J, Kjaer M, Aagaard P, Magnusson SP, Couppe C. Effect of Low-Load Blood-Flow Restricted Training Versus Heavy Slow Resistance Training in Unilateral Patellar Tendinopathy: A Randomized Clinical Trial. Scand J Med Sci Sports. 2025 Dec;35(12):e70186. doi: 10.1111/sms.70186.

    PubMed 41452311

Questions about this trial

What is this clinical trial studying?

A study testing Heavy-Slow Resistance training and Low-Load Blood Flow Restriction training in people with Patellar Tendinopathy and Jumper's Knee, run by Bispebjerg Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline - 12 weeks using the clinical functional test Single-Leg Decline Squat measured on the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain) (time frame: Baseline-12 weeks.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04550013, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in